Clinical Report: May OPO Perfusion Expand Liver Use?
Overview
A portable hypothermic oxygenated machine perfusion strategy has shown promising results in liver transplantation, achieving 100% patient and graft survival in a small cohort of 18 patients. This approach may enhance the viability of higher-risk donor organs, particularly from donation-after-circulatory-death donors.
Background
The demand for donor organs for transplantation continues to rise, while donation rates remain static, creating a critical need for innovative preservation techniques. Machine perfusion, particularly hypothermic oxygenated perfusion, is being explored as a method to improve organ viability and expand the donor pool. This study evaluates the feasibility and outcomes of a portable machine perfusion strategy initiated by an organ procurement organization.
Data Highlights
| Parameter | Value |
|---|---|
| Patient and graft survival | 100% |
| Total patients | 18 |
| Median follow-up | 449 days |
| Median donor age | 59.5 years |
| Median BMI | 27 kg/m |
| Median cold ischemia time | 582 minutes |
| Early allograft dysfunction | 1 patient |
| Adverse events | Early bile leak, anastomotic biliary stricture, acute cellular rejection |
Key Findings
- 100% patient and graft survival at a median follow-up of 449 days.
- 67% of donors were donation-after-circulatory-death donors.
- Median time from cross-clamp to HMP-O2 initiation was 105 minutes.
- 39% of grafts were accepted after late preoperative or post-cross-clamp declines.
- No cases of ischemic cholangiopathy or primary nonfunction were observed.
- Posttransplant outcomes were similar between OPO-initiated and transplant center–initiated HMP-O2 groups.
- Adverse events included early bile leak, anastomotic biliary stricture, and acute cellular rejection.
Clinical Implications
The findings suggest that portable hypothermic oxygenated machine perfusion can be effectively implemented by organ procurement organizations, potentially increasing the availability of donor livers. Clinicians should consider this strategy when evaluating higher-risk donor organs to improve transplantation outcomes, including training for staff on the use of the perfusion device.
Conclusion
The study supports the feasibility of OPO-initiated portable machine perfusion for liver transplantation, indicating a potential pathway to expand the donor organ pool. However, the study is limited by its small sample size and single-center design. Further research is warranted to validate these findings in larger cohorts.
Related Resources & Content
- Haugen CE, Guarrera JV, Quillin RC III, Surgery, 2023 -- May OPO Perfusion Expand Liver Use?
- Current Uses and Future Perspectives of Ex Vivo Machine Perfusion in Liver Transplantation, 2020
- EASL Clinical Practice Guidelines on Liver Transplantation, 2024
- Enhancing Liver Size for Complex Hepatic Surgery and Partial Transplantation: Current Advances in Parenchyma Augmentation Techniques
- Intensive Care Medicine — Respiratory Complications Associated with Liver Disease
- Hypothermic Machine Perfusion in Liver Transplantation - A Randomized Trial
- Prolonged Dual Hypothermic Oxygenated Machine Perfusion for Daytime Liver Transplant
- JOURNAL OF HEPATOLOGYClinical Practice GuidelinesE
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
